COVID-19: Daicel Offers New Device: Osaka University / Anges / Vaccine Development
March 13, 2020
COVID-19: Daicel
Daicel provides new administration device “Actanza ™ Lab” technology for developing DNA vaccine for COVID-19.
The other day, Osaka University and Anges have started developing a DNA vaccine for a new coronavirus.
New dosing device: Actlanza ™ Lab
Daicel will provide “Actanza ™ Lab” technology, a new dispensing device that delivers drugs into cells, for this joint development.
By using this new administration device during administration, the gene expression efficiency and the antibody productivity of DNA vaccines are improved.
More effective DNA vaccine development can be expected.
<Overview of the new administration device “Actanza ™ Lab”>
A technology that uses a gunpowder as a driving force to deliver a drug solution into a specific tissue without using a needle.
Compared to conventional needle injection, it has been reported that the gene expression efficiency is improved in addition to the accuracy of the delivery location.
Vaccines are more efficient in skin because they have more immunocompetent cells than in muscle.
News 2020 | Daicel Corporation
https://www.daicel.com/news/2020/20200313_221.html